Ligne de temps

Vincent Bondet
Ingénieur(e) de Recherche
15 nov. 2023
news

New publication – Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

Lire plus
09 août 2023
publication

Dissecting human population variation in single-cell responses to SARS-CoV-2

Lire plus
01 août 2023
publication

Heterogeneity and functions of the 13 IFN-α subtypes – lucky for some?

Lire plus
12 mai 2023
publication

JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study.

Lire plus
01 avr. 2023
publication

Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus.

Lire plus
17 janv. 2023
publication

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets.

Lire plus
05 déc. 2022
publication

Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.

Lire plus
25 nov. 2022
publication

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Lire plus
15 nov. 2022
publication

Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.

Lire plus
28 juin 2022
publication

Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.

Lire plus
20 juin 2022
publication

Variability of Primary Sjögren’s Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.

Lire plus
09 juin 2022
publication

Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.

Lire plus
18 avr. 2022
publication

CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue.

Lire plus
31 mars 2022
publication

Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus.

Lire plus
28 mars 2022
news

New publication – Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency

Lire plus
23 févr. 2022
publication

Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study.

Lire plus
14 févr. 2022
publication

Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency.

Lire plus
01 févr. 2022
publication

Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old.

Lire plus
01 janv. 2022
publication

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.

Lire plus
01 sept. 2021
publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Lire plus
23 août 2021
publication

Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection.

Lire plus
01 août 2021
publication

Differential levels of IFNα subtypes in autoimmunity and viral infection.

Lire plus
04 juin 2021
publication

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.

Lire plus
01 mai 2021
publication

HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART.

Lire plus
01 avr. 2021
publication

Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies.

Lire plus
12 févr. 2021
publication

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.

Lire plus
01 févr. 2021
publication

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.

Lire plus
04 janv. 2021
publication

TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons.

Lire plus
01 janv. 2021
publication

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.

Lire plus
01 janv. 2021
publication

Constitutive IFNα Protein Production in Bats.

Lire plus
02 nov. 2020
publication

Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling.

Lire plus
24 sept. 2020
publication

Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa.

Lire plus
19 sept. 2020
publication

Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.

Lire plus
13 juil. 2020
publication

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

Lire plus
02 juil. 2020
team

Immunologie Translationnelle

Lire plus
22 juin 2020
publication

Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Lire plus
19 juin 2020
publication

Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption.

Lire plus
05 juin 2020
publication

Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.

Lire plus
05 mars 2020
publication

The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway

Lire plus
01 janv. 2020
publication

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.

Lire plus
13 déc. 2019
publication

Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in

Lire plus
26 nov. 2019
publication

Cardiac valve involvement in -related type I interferonopathy

Lire plus
26 nov. 2019
publication

PSMB10, the last immunoproteasome gene missing for PRAAS

Lire plus
22 nov. 2019
publication

Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling

Lire plus
30 oct. 2019
publication

Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage

Lire plus
30 oct. 2019
publication

Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology

Lire plus
05 oct. 2019
publication

Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers

Lire plus
05 sept. 2019
publication

Circulating interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity

Lire plus
22 août 2019
publication

Plasma Type I IFN Protein Concentrations in Human Tuberculosis

Lire plus
10 juil. 2019
publication

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment

Lire plus
14 juin 2019
publication

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

Lire plus
22 mai 2019
publication

IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay

Lire plus
08 avr. 2019
publication

Delineating the healthy human skin UV response and early induction of interferon pathway in cutaneous lupus erythematosus

Lire plus
07 mars 2019
publication

Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined

Lire plus
18 févr. 2019
publication

Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth

Lire plus
04 janv. 2019
team

Plate-Forme Technologique Production et Purification de Protéines Recombinantes

Lire plus
06 déc. 2018
publication

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Lire plus
01 nov. 2018
publication

A child with severe juvenile dermatomyositis treated with ruxolitinib

Lire plus
03 oct. 2018
publication

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

Lire plus
07 sept. 2018
publication

First description of agonist and antagonist IP-10 in urine of patients with active TB

Lire plus
05 juil. 2018
publication

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions

Lire plus
14 juin 2018
publication

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Lire plus
01 juin 2018
publication

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

Lire plus
01 juin 2018
publication

Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou : mutations in result in a constitutive activation of type I interferon signalling

Lire plus
19 déc. 2017
publication

Type I interferon-mediated autoinflammation due to DNase II deficiency

Lire plus
20 avr. 2017
publication

TBK1/IKKE blockade inhibits mutant STING mediated inflammatory response in patient cells

Lire plus
18 avr. 2017
publication

Detection of interferon alpha protein reveals differential levels and cellular sources in disease

Lire plus
10 sept. 2015
project

Biomarker discovery and viral disease pathogenesis

Lire plus
10 sept. 2015
project

Functional immune response to Mycobacteria tuberculosis derived antigen

Lire plus
11 oct. 2013
publication

Structural and functional characterization of an orphan ATP-binding cassette ATPase involved in manganese utilization and tolerance in Leptospira spp

Lire plus
27 juil. 2007
publication

The crystal structure of M. leprae ML2640c defines a large family of putative S-adenosylmethionine-dependent methyltransferases in mycobacteria

Lire plus